Grant, JM, Mottet, LA, Tanis, J. Injustice at Every Turn. A Report of the National Transgender Discrimination Survey. National Center for Transgender Equality and National Gay and Lesbian Task Force. Washington, DC: 2011. Available from: https://transequality.org/sites/default/files/docs/resources/NTDS_Report.pdfGoogle Scholar

Flütsch, N. Survey on the acceptance of terms related to the genital organs altered by testosterone, 2019–2021 (yet not published). Available from: www.FTM-Portal.netGoogle Scholar

Defreyne, J, Elaut, E, Den Heijer, M, et al. Sexual orientation in transgender individuals: results from the longitudinal ENIGI study. Int J Impot Res 2021 (online). https://doi.org/10.1038/s41443–020-00402-7Google Scholar

Shaw, PA. The history of cervical screening part I. J Soc Obstet Gynaecol Can 2000;22(2):110–114.Google Scholar

Schoell, WM, Janicek, MF, Mirhashemi, R. Epidemiology and biology of cervical cancer. Semin Surg Oncol 1999;16(3):203–211.Google Scholar

Giuliano, AR, Anic, G, Nyitray, AG. Epidemiology and pathology of HPV disease in males. Gynecol Oncol 2010;117(2 Suppl):S15–19.CrossRefGoogle ScholarPubMed

Zhiyue, L, Nyitray, AG, Hwang, LY, et al. Acquisition, persistence, and clearance of human papillomavirus infection among male virgins residing in Brazil, Mexico, and the United States. J Inf Dis 2018;5:767–776.Google Scholar

Zhiyue, L, Rashid, T, Nyitray, AG. Penises not required: a systematic review of the potential for human papillomavirus horizontal transmission that is non-sexual or does not include penile penetration. Sex Health 2016;13(1):10–21.Google Scholar

Coleman, E., et al. Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version VII. Int J Transgend 2012;13(4):165–232.CrossRefGoogle Scholar

Rahman, M, Li, DH, Moskowitz, DA. Comparing the healthcare utilization and engagement in a sample of transgender and cisgender bisexual+ persons. Arch Sex Behav 2019;48(1):255–260.CrossRefGoogle Scholar

Thomsen, LT, Kjær, SK, Munk, C, et al. Clinical performance of human papillomavirus (HPV) testing versus cytology for cervical cancer screening: results of a large Danish implementation study. Clin Epidemiol 2020;12:203–213.CrossRefGoogle ScholarPubMed

Canfell, K, Caruana, M, Gebski, V, et al. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: results of the Compass pilot randomised trial. PLOS ONE 2017;14(9):e1002388.Google ScholarPubMed

S3 guideline prevention of cervical carcinoma long version 1.1. March 2020. AWMF register number 015/027OL. Available from: www.awmf.org/leitlinien/detail/ll/015-027OL.htmlGoogle Scholar

Stokes-Lampard, H, Wilson, S, Waddel, Cl, et al. Vaginal vault smears after hysterectomy for reasons other than malignancy: a systematic review of the literature. BJOG 2006;113(12):1354–1365.Google Scholar

Elaut, E, Weyers, S, Hoeboeke, P, Stockman, S, Monstrey, S. Sexuality and relationships of transgender people. In Bouman, WP and Arcelus, J, Eds. The Transgender Handbook. New York, NY: Nova Science Publishers, 2017, Chapter 10.Google Scholar

Buncamper, ME, Honselaar, JS, Bouman, MB, et al.. Aesthetic and functional outcomes of neovaginoplasty using penile skin in male-to-female transsexuals. J Sex Med 2015;12:1626–1634.Google Scholar

Opsomer, D, Gast, KM, Lisa Ramaut, L, et al. Creation of clitoral hood and labia minora in penile inversion vaginoplasty in circumcised and uncircumcised transwomen. Plast Reconstr Surg 2018;142(5):729e–733e.Google Scholar

Van der Grift, T, Cohen-Kettenis, PT, Steensma, T, et al. Body satisfaction and physical appearance in gender dysphoria. Arch Sex Behav 2016;45:575–585.Google Scholar

Stowell, JT, Grimstad, FW, Kirkpatrick, DL, et al. Imaging findings in transgender patients after gender-affirming surgery. Radiographics 2019;39(5):1368–1392.Google Scholar

Stowell, JT, Garner, HW, Herrmann, S, Tilson, K, Stanborough, RO. Bone health of transgender adults: what the radiologist needs to know. Skeletal Radiol 2020;49(10):1525–1537.Google Scholar

Grimstad, FW, Stowell, JT, Gaddis, M. Survey of experiences of transgender and gender nonbinary patients during imaging encounters and opportunities for improvement. Am J Roentgenol 2020;215(5):1136–1142.Google Scholar

Kirkpatrick, DL, Stowell, J, Grimstad, F, et al. Creating a transgender-inclusive interventional radiology department. J Vasc Interv Radiol 2019;30(6):928–931.CrossRefGoogle ScholarPubMed

Goldberg, JE, Moy, L, Rosenkrantz, AB. Assessing transgender patient care and gender inclusivity of breast imaging facilities across the United States. J Am Coll Radiol 2018;15(8):1164–1172.CrossRefGoogle ScholarPubMed

Wierckx, K, Gooren, L, T’Sjoen, G. Clinical review: breast development in trans women receiving cross-sex hormones. J Sex Med 2014;11(5):1240–1247.Google Scholar

Maycock, LB, Kennedy, HP. Breast care in the transgender individual. J Midwifery Women’s Health 2014;59(1):74–81.CrossRefGoogle ScholarPubMed

Maglione, KD, Margolies, L, Jaffer, S, et al. Breast cancer in male-to-female transsexuals: use of breast imaging for detection. Am J Roentgenol 2014;203(6):W735–W740.CrossRefGoogle ScholarPubMed

Lemmo, G, Garcea, N, Corsello, S, et al. Breast fibroadenoma in a male-to-female transsexual patient after hormonal treatment. Eur J Surg Suppl. 2003;(588):69–71.Google Scholar

Phillips, J, Fein-Zachary, VJ, Mehta, TS, et al. Breast imaging in the transgender patient. Am J Roentgenol 2014;202(5):1149–1156.Google Scholar

Reisman, T, Goldstein, Z. Case report: induced lactation in a transgender woman. Transgend Health 2018;3(1):24–26.Google Scholar

Weyers, S, Villeirs, G, Vanherreweghe, E, et al. Mammography and breast sonography in transsexual women. Eur J Radiol 2010;74(3):508–513.Google Scholar

Freer, PE. Mammographic breast density: impact on breast cancer risk and implications for screening. Radiographics 2015;35(2):302–315.Google Scholar

Brown, GR, Jones, KT. Incidence of breast cancer in a cohort of 5,135 transgender veterans. Breast Cancer Res Treat 2015;149(1):191–198.Google Scholar

de Blok, CJM, Wiepjes, CM, Nota, NM, et al. Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands. Br Med J 2019;365:1652.CrossRefGoogle ScholarPubMed

Gooren, L, Bowers, M, Lips, P, Konings, IR. Five new cases of breast cancer in transsexual persons. Andrologia 2015;47(10):1202–1205.CrossRefGoogle ScholarPubMed

Hartley, RL, Stone, JP, Temple-Oberle, C. Breast cancer in transgender patients: a systematic review. Part 1: male to female. Eur J Surg Oncol 2018;44(10):1455–1462.Google Scholar

Joint, R, Chen, ZE, Cameron, S. Breast and reproductive cancers in the transgender population: a systematic review. BJOG 2018;125(12):1505–1512.Google Scholar

McFarlane, T, Zajac, JD, Cheung, AS. Gender-affirming hormone therapy and the risk of sex hormone-dependent tumours in transgender individuals: a systematic review. Clin Endocrinol 2018;89(6):700–711.CrossRefGoogle ScholarPubMed

Corman, V, Potorac, I, Manto, F, et al. Breast cancer in a male-to-female transsexual patient with a BRCA2 mutation. Endocrine-Related Cancer 2016;23(5):391–397.CrossRefGoogle Scholar

Narayan, A, Lebron-Zapata, L, Morris, E. Breast cancer screening in transgender patients: findings from the 2014 BRFSS survey. Breast Cancer Res Treat 2017;166(3):875–879.CrossRefGoogle ScholarPubMed

Bazzi, AR, Whorms, DS, King, DS, Potter, J. Adherence to mammography screening guidelines among transgender persons and sexual minority women. Am J Public Health 2015;105(11):2356–2358.Google Scholar

Huang, S-Y, Zhang, M, David, M. Radiology’s engagement with transgender breast imaging: review of radiology practice websites and publications. J Breast Imaging 2020;2(2):147–151.CrossRefGoogle Scholar

Mainiero, MB, Moy, L, Baron, P, et al. ACR appropriateness criteria® breast cancer screening. J Am Coll Radiol 2017;14(11s):S383–S390.CrossRefGoogle ScholarPubMed

Shah, AT, Jankharia, BB. Imaging of common breast implants and implant-related complications: a pictorial essay. Indian J Radiol Imaging 2016;26(2):216–225.Google ScholarPubMed

Parikh, U, Mausner, E, Chhor, CM, et al. Breast imaging in transgender patients: what the radiologist should know. Radiographics 2020;40(1):13–27.CrossRefGoogle ScholarPubMed

Stone, JP, Hartley, RL, Temple-Oberle, C. Breast cancer in transgender patients: a systematic review. Part 2: female to male. Eur J Surg Oncol 2018;44(10):1463–1468.Google Scholar

Torous, VF, Schnitt, SJ. Histopathologic findings in breast surgical specimens from patients undergoing female-to-male gender reassignment surgery. Mod Pathol 2019;32(3):346–353.Google Scholar

East, EG, Gast, KM, Kuzon, WM Jr., et al. Clinicopathological findings in female-to-male gender-affirming breast surgery. Histopathology 2017;71(6):859–865.Google Scholar

Grynberg, M, Fanchin, R, Dubost, G, et al. Histology of genital tract and breast tissue after long-term testosterone administration in a female-to-male transsexual population. Reproductive BioMedicine Online 2010;20(4):553–558.CrossRefGoogle Scholar

Bentz, E-K, Pils, D, Bilban, M, et al. Gene expression signatures of breast tissue before and after cross-sex hormone therapy in female-to-male transsexuals. Fertil Steril 2010;94(7):2688–2696.Google Scholar

Salvi, S, Bonafè, M, Bravaccini, S. Androgen receptor in breast cancer: a wolf in sheep’s clothing? A lesson from prostate cancer. Semin Cancer Biol 2020;60:132–137.Google Scholar

Wolter, A, Diedrichson, J, Scholz, T, Arens-Landwehr, A, Liebau, J. Sexual reassignment surgery in female-to-male transsexuals: an algorithm for subcutaneous mastectomy. J Plast Reconstr Aesthet Surg 2015;68(2):184–191.Google Scholar

Center of Excellence for Transgender Health DoF, Community Medicine UoCSF. Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People; 2nd ed.Google Scholar

Woitek, R, Pfeiler, G, Farr, A, et al. MRI-based quantification of residual fibroglandular tissue of the breast after conservative mastectomies. Eur J Radiol 2018;104:1–7.CrossRefGoogle ScholarPubMed

Perrone, AM, Cerpolini, S, Maria Salfi, NC, et al. Effect of long-term testosterone administration on the endometrium of female‐to‐male (FtM) transsexuals. J Sex Med 2009;6(11):3193–3200.CrossRefGoogle ScholarPubMed

Grimstad, FW, Fowler, KG, New, EP, et al. Uterine pathology in transmasculine persons on testosterone: a retrospective multicenter case series. Am J Obstet Gynecol 2019;220(3):257.e251–257.Google Scholar

Futterweit, W, Deligdisch, L. Histopathological effects of exogenously administered testosterone in 19 female to male transsexuals. J Clin Endocrinol Metab 1986;62(1):16–21.CrossRefGoogle Scholar

Grimstad, FW, Boskey, E, Grey, M. New-onset abdominopelvic pain after initiation of testosterone therapy among trans-masculine persons: a community-based exploratory survey. LGBT Health 2020;7(5):248–253.Google Scholar

Chadha, S, Pache, TD, Huikeshoven, JM, Brinkmann, AO, van der Kwast, TH. Androgen receptor expression in human ovarian and uterine tissue of long-term androgen-treated transsexual women. Hum Pathol 1994;25(11):1198–1204.Google Scholar

Ikeda, K, Baba, T, Noguchi, H, et al. Excessive androgen exposure in female-to-male transsexual persons of reproductive age induces hyperplasia of the ovarian cortex and stroma but not polycystic ovary morphology. Hum Reprod 2013;28(2):453–461.Google Scholar

Caanen, MR, Schouten, NE, Kuijper, EAM, et al. Effects of long-term exogenous testosterone administration on ovarian morphology, determined by transvaginal (3D) ultrasound in female-to-male transsexuals. Hum Reprod 2017;32(7):1457–1464.CrossRefGoogle ScholarPubMed

Grimstad, FW, Fowler, KG, New, EP, et al. Ovarian histopathology in transmasculine persons on testosterone: a multicenter case series. J Sex Med 2020;17(9):1807–1818.CrossRefGoogle ScholarPubMed

Robbins, JB, Sadowski, EA, Maturen, KE, et al. ACR appropriateness criteria® abnormal uterine bleeding. J Am Coll Radiol 2020;17(11s):S336–S345.CrossRefGoogle ScholarPubMed

Bhosale, PR, Javitt, MC, Atri, M, et al. ACR appropriateness criteria® acute pelvic pain in the reproductive age group. Ultrasound Q 2016;32(2):108–115.Google Scholar

American Institute of Ultrasound in Medicine (AIUM). Practice parameter for the performance of an ultrasound examination of the female pelvis. J Ultrasound Med 2020;39(5):E17–23.Google Scholar

Mueller, A, Kiesewetter, F, Binder, H, Beckmann, MW, Dittrich, R. Long-term administration of testosterone undecanoate every 3 months for testosterone supplementation in female-to-male transsexuals. J Clin Endocrinol Metab 2007;92(9):3470–3475.Google Scholar

Mueller, A, Haeberle, L, Zollver, H, et al. Effects of intramuscular testosterone undecanoate on body composition and bone mineral density in female-to-male transsexuals. J Sex Med 2010;7(9):3190–3198.Google Scholar

den Heijer, M, Bakker, A, Gooren, L. Long-term hormonal treatment for transgender people. Br Med J 2017;359:j5027.Google Scholar

Braun, H, Nash, R, Tangpricha, V, et al. Cancer in transgender people: evidence and methodological considerations. Epidemiol Rev 2017;39(1):93–107.Google Scholar

Grimstad, FW, Fowler, KG, New, EP, et al. Ovarian histopathology in transmasculine persons on testosterone: a multicenter case series. J Sex Med 2020;17(9):1807–1818.CrossRefGoogle ScholarPubMed

Urban, RR, Teng, NNH, Kapp, DS. Gynecologic malignancies in female-to-male transgender patients: the need of original gender surveillance. Am J Obstet Gynecol 2011;204(5):e9–e12.Google Scholar

Hage, JJ, Dekker, JJML, Karim, RB, Verheijen, RHM, Bloemena, E. Ovarian cancer in female-to-male transsexuals: report of two cases. Gynecol Oncol 2000;76(3):413–415.Google Scholar

Dizon, DS, Tejada-Berges, T, Koelliker, S, Steinhoff, M, Granai, CO. Ovarian cancer associated with testosterone supplementation in a female-to-male transsexual patient. Gynecol Obstet Invest 2006;62(4):226–228.CrossRefGoogle Scholar

Trum, HW, Hoebeke, P, Gooren, LJ. Sex reassignment of transsexual people from a gynecologist’s and urologist’s perspective. Acta Obstetricia et Gynecologica Scandinavica 2015;94(6):563–567.Google Scholar

Weyers, S, Decaestecker, K, Verstraelen, H, et al. Clinical and transvaginal sonographic evaluation of the prostate in transsexual women. Urology 2009;74(1):191–196.Google Scholar

Gooren, L, Morgentaler, A. Prostate cancer incidence in orchidectomised male-to-female transsexual persons treated with oestrogens. Andrologia 2014;46(10):1156–1160.Google Scholar

Deebel, NA, Morin, JP, Autorino, R, et al. Prostate cancer in transgender women: incidence, etiopathogenesis, and management challenges. Urology 2017;110:166–171.Google Scholar

Jin, B, Turner, L, Walters, AW, Handelsman, DJ. Androgen or estrogen effects on human prostate. J Clin Endocrinol Metab 1996;81(12):4290–4295.Google Scholar

Zhang, SJ, Qian, HN, Zhao, Y, et al. Relationship between age and prostate size. Asian J Androl 2013;15(1):116–120.CrossRefGoogle ScholarPubMed

van Kesteren, P, Meinhardt, W, van der Valk, P, et al. Effects of estrogens only on the prostates of aging men. J Urol 1996;156(4):1349–1353.Google Scholar

Coakley, FV, Oto, A, Alexander, LF, et al. ACR appropriateness criteria® prostate cancer: pre-treatment detection, surveillance, and staging. J Am Coll Radiol 2017;14(5s):S245–S257.Google Scholar

Gawlitza, J, Reiss-Zimmermann, M, Thörmer, G, et al. Impact of the use of an endorectal coil for 3 T prostate MRI on image quality and cancer detection rate. Scientific Rep 2017;7:40640.Google Scholar

Jindarak, S, Nilprapha, K, Atikankul, T, et al. Spermatogenesis abnormalities following hormonal therapy in transwomen. Biomed Res Int 2018;2018:7919481.Google Scholar

Kent, MA, Winoker, JS, Grotas, AB. Effects of feminizing hormones on sperm production and malignant changes: microscopic examination of post orchiectomy specimens in transwomen. Urology 2018;121:93–96.Google Scholar

Schneider, F, Neuhaus, N, Wistuba, J, et al. Testicular functions and clinical characterization of patients with gender dysphoria (GD) undergoing sex reassignment surgery (SRS). J Sex Med 2015;12(11):2190–2200.CrossRefGoogle ScholarPubMed

Jiang, DD, Swenson, E, Mason, M, et al. Effects of estrogen on spermatogenesis in transgender women. Urology 2019;132:117–122.CrossRefGoogle ScholarPubMed

Wolf-Gould, CS, Wolf-Gould, CH. A transgender woman with testicular cancer: a new twist on an old problem. LGBT Health 2016;3(1):90–95.Google Scholar

Chandhoke, G, Shayegan, B, Hotte, SJ. Exogenous estrogen therapy, testicular cancer, and the male to female transgender population: a case report. J Med Case Rep 2018;12(1):373.Google Scholar

Kvach, EJ, Hyer, JS, Carey, JC, Bowers, M. Testicular seminoma in a transgender woman: a case report. LGBT Health 2019;6(1):40–42.Google Scholar

Fighera, TM, Ziegelmann, PK, Rasia da Silva, T, Spritzer, PM. Bone mass effects of cross-sex hormone therapy in transgender people: updated systematic review and meta-analysis. J Endocr Soc 2019;3(5):943–964.Google Scholar

Wiepjes, CM, de Jongh, RT, de Blok, CJ, et al. Bone safety during the first ten years of gender-affirming hormonal treatment in transwomen and transmen. J Bone Miner Res 2019;34(3):447–454.Google Scholar

Wiepjes, CM, de Blok, CJ, Staphorsius, AS, et al. Fracture risk in trans women and trans men using long-term gender-affirming hormonal treatment: a nationwide cohort study. J Bone Miner Res 2020;35(1):64–70.Google Scholar

Rosen, HN, Hamnvik, OR, Jaisamrarn, U, et al. Bone densitometry in transgender and gender non-conforming (TGNC) individuals: 2019 ISCD official position. J Clin Densitom 2019;22(4):544–553.CrossRefGoogle ScholarPubMed

Fighera, TM, da Silva, ED, Borba, GDS, Spritzer, PM. Does (mis)use of industrial liquid silicone implants interfere with bone mineral density in transgender women? Arch Osteoporos 2020;15(1):149.Google Scholar

Coombes, GB, Reiser, J, Paradinas, FJ, Burn, I. An androgen-associated hepatic adenoma in a trans-sexual. Br J Surg 1978;65(12):869–870.Google Scholar

Bird, D, Vowles, K, Anthony, PP. Spontaneous rupture of a liver cell adenoma after long term methyltestosterone: report of a case successfully treated by emergency right hepatic lobectomy. Br J Surg 1979;66(3):212–213.CrossRefGoogle ScholarPubMed

Zou, Y, Szczesniak, R, Teeters, A, Conard, LA, Grossoehme, D. Documenting an epidemic of suffering: low health-related quality of life among transgender youth. Qual Life Res 2018;27(8):2107–2115.Google Scholar

Mirabella, M, Giovanardi, G, Fortunato, A, et al. The body I live in. Perceptions and meanings of body dissatisfaction in young transgender adults: a qualitative study. J Clin Med 2020;9(11):3733.Google Scholar

Battegay, E, Bassetti, S. Dissimulation und Maskierung von Symptomen und Befunden. In Battegay, E, Ed. Differenzialdiagnose Innerer Krankheiten. Stuttgart: Thieme, 2017, p. 50.Google Scholar

Defreyne, J, Vanwonterghem, Y, Collet, S, et al. Vaginal bleeding and spotting in transgender men after initiation of testosterone therapy: a prospective cohort study (ENIGI). Int J Transgend Health 2020;21(2):163–175.Google Scholar

Sitruk Ware, R. Pharmacological profile of progestins. Maturitas 2008;61(1–2):151–157.Google Scholar

Chu, MC, Zhang, X, Gentzschein, E, Stanczyk, KZ, Lobo, RA. Formation of ethinyl estradiol in women during treatment with norethindrone acetate. J Clin Endocrinol Metab 2007;92(6):2205–2207.Google Scholar

Hawkins, M, Deutsch, MB, Obedin-Maliver, J, et al. Endometrial findings among transgender and gender nonbinary people using testosterone at the time of gender-affirming hysterectomy. Fertil Steril 2021;115(5):1312–1317.Google Scholar

Ahrendt, HJ, Tylkoski, H, Rabe, T, et al. Prevalence of uterine myomas in women in Germany: data of an epidemiological study. Arch Gyn Obst 2016;293:1243–1253.Google Scholar

Stewart, EA, Cookson, CL, Gandolfo, RA, Schulze-Rath, R. Epidemiology of uterine fibroids: a systematic review. BJOG 2017;124(10):1501–1512.Google Scholar

Fasih, N, Shanbhogue, AKP, Macdonald, DB, et al. Leiomyomas beyond the uterus: unusual locations, rare manifestations. Radiographics 2008;28:1931–1948.CrossRefGoogle ScholarPubMed

Pallavee, P, Seetesh, G, Samal, S, Begum, J, Zabeen, M. Fibroid after hysterectomy: a diagnostic dilemma. J Clin Diagn Res 2014;8(7):OD01–OD02.Google Scholar

Donnez, J, Dolmans, MM. Uterine fibroid management: from the present to the future. Hum Reprod Update 2016;22(6): 665–686.Google Scholar

Blake, RE. Leiomyomata uteri: hormonal and molecular determinants of growth. J Natl Med Assoc 2007;9(10):1170–1178.Google Scholar

Ke, LQ, Yang, K, Li, J, Li, CM. Danazol for uterine fibroids. Cochrane Database Syst Rev 2009;2009:CD007692.Google Scholar

Lan, M, Li, H, Bao, L, et al. In vivo evidence of the androgen receptor in association with myometrial cell proliferation and apoptosis. Reprod Sci 2016;23(2):264–271.CrossRefGoogle ScholarPubMed

Bulun, SE, Imir, G, Utsunomiya, H, et al. Aromatase in endometriosis and uterine leiomyomata. J Steroid Biochem Molec Biol 2005;95:57–62.Google Scholar

Wong, JYY, Gold, EB, Johnson, WO, Lee, JS. Circulating sex hormones and risk of uterine fibroids: Study of Women’s Health Across the Nation (SWAN). J Clin Endocrinol Metab 2016;101(1):123–130.Google Scholar

Sadowski, EA, Paroder, V, Patel-Lippmann, K, et al. Indeterminate adnexal cysts at US: prevalence and characteristics of ovarian cancer. Radiology 2018;287(3):1041–1049.Google Scholar

Timmerman, D, Valentin, L, Bourne, TH, et al. Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) Group. Ultrasound Obstet Gynecol 2000;16(5):500–505.Google Scholar

Van Trotsenburg, M. Necessity and validity of transabdominal ultrasound for FtMs. Presentation at the session on gynecology, WPATH biennial symposium, September 2011, Atlanta (not yet published).Google Scholar

Deswal, R, Narwal, V, Dang, A, Pundir, CS. The prevalence of polycystic ovary syndrome: a brief systematic review. J Hum Reprod Sci 2020;13(4):261–271.Google Scholar

Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81(1):19–25.Google Scholar

Khorshidi, A, Azami, M, Tardeh, S, Tardeh, Z. The prevalence of metabolic syndrome in patients with polycystic ovary syndrome: a systematic review and meta-analysis. Diabetes Metab Syndr 2019;13(4):2747–2753.Google Scholar

Moghetti, F, Tosi, F. Insulin resistance and PCOS: chicken or egg? J Endocrinol Invest 2021;44(2):233–244.Google Scholar

Sanchez-Garrido, MA, Tena-Sempere, M. Metabolic dysfunction in polycystic ovary syndrome: pathogenic role of androgen excess and potential therapeutic strategies. Mol Metab 2020;35:100937.CrossRefGoogle ScholarPubMed

Diamanti-Kandarakis, E, Papalou, O, Kandaraki, EA. The role of androgen excess on insulin sensitivity in women. In Pasquali, R, Pignatelli, D, Eds. Hyperandrogenism in Women. Beyond Polycystic Ovary Syndrome. Basel: Karger, 2019;53:50–64.Google Scholar

Caanen, MR, Schouten, NE, Kuijper, EM, et al. Effects of long-term exogenous testosterone administration on ovarian morphology, determined by transvaginal (3D) ultrasound in female-to-male transsexuals. Hum Reprod 2017;32(7):1457–1464.Google Scholar

Mück, AO, Seeger, H. Hormone therapy after endometrial cancer. Endocr Rel Cancer 2004;11(2):305–314.CrossRefGoogle Scholar

Pillay, OC, Wong Te Fonf, LF, Crow, JC, et al. The association between polycystic ovaries and endometrial cancer. Hum Reprod 2006;21(4):924–929.Google Scholar

Skorska, MA, Bogaert, AF. Prenatal androgens in men’s sexual orientation: evidence for a more nuanced role. Arch Sex Behav 2017;46:1621–1624.Google Scholar

Dörner, G, Götz, F, Rohde, W, et al. Genetic and epigenetic effects on sexual brain organization mediated by sex hormones. Neuro Endocrinol Lett 2001;22(6):403–409.Google Scholar

Bosinski, HA, Peter, M, Bonatz, G, et al. A higher rate of hyperandrogenic disorders in female-to-male transsexuals. Psychoneuroendocrinology 1997;22(5):361–380.CrossRefGoogle ScholarPubMed

Amerikia, H, Savoy-Moore, RT, Sundareson, AS, Moghissi, KS. The effects of long-term androgen treatment on the ovary. Fertil Steril 1986;45(29):202–208.Google Scholar

Ikeda, K, Baba, T, Noguchi, H, et al. Excessive androgen exposure in female-to-male transsexual persons of reproductive age induces hyperplasia of the ovarian cortex and stroma but not polycystic ovary morphology. Hum Reprod 2013;28(2):453–461.Google Scholar

Ghai, V, Haider, J, Fevzi, S, Haines, P, Kent, A. Diagnostic delay for superficial and deep endometriosis in the United Kingdom. J Obstet Gynaecol 2020;40(1):83–89.Google Scholar

Zondervan, KT, Becker, CM, Missmer, SA. Endometriosis. N Engl J Med 2020;382(13):1244–1256.Google Scholar

Ferrando, CA, Chapman, G, Pollard, R. Preoperative pain symptoms and the incidence of endometriosis in transgender men undergoing hysterectomy for gender affirmation. J Minim Invas Gynecol 2021;28(9):1579–1584.Google Scholar

Serdar, E, Bulun, SE, Monsavais, D, et al. Role of estrogen receptor-β in endometriosis. Semin Reprod Med 2012;30(1):39–45.Google Scholar

Patel, S. Disruption of aromatase homeostasis as the cause of a multiplicity of ailments: a comprehensive review. J Steroid Biochem Mol Biol 2017;168:19–25.CrossRefGoogle ScholarPubMed

Słopień, R, Męczekalski, B. Review on aromatase inhibitors in the treatment of endometriosis. Menopause Rev 2016;15(1):43–47.Google Scholar

Yanyan-Hong, Y, Chen, S. Aromatase inhibitors. Structural features and biochemical characterization. Ann NY Acad Sci 2006;1089:237–251.Google Scholar

Meriggiola, MC, Armillotta, F, Costantino, A, et al. Effects of testosterone undecanoate administered alone or in combination with letrozole or dutasteride in female to male transsexuals. J Sex Med 2008;5(10):2442–2453.Google Scholar

Shim, JY, Laufer, MR, Grimstad, FW. Dysmenorrhea and endometriosis in transgender adolescents. J Pediatr Adolesc Gynecol 2020;33(5):524–528.Google Scholar

Irwin, DE, Milsom, I, Hunskaar, S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 2006;50(6):1306–1315.Google Scholar

Lai, HH, Shen, B, Rawal, A, Vetter, J. The relationship between depression and overactive bladder/urinary incontinence symptoms in the clinical OAB population. BMC Urol 2016;16(1):60.CrossRefGoogle ScholarPubMed

Hoebeke, P, Selvaggi, G, Ceulemans, P, et al. Impact of sex reassignment surgery on lower urinary tract function. Eur Urol 2005;47(3):398–402.Google Scholar

Kuhn, A, Hiltebrand, R, Birkhäuser, M. Do transsexuals have micturition disorders? Eur J Obstet Gynecol Reprod Biol 2007;131(2):226–230.Google Scholar

Choi, H, Chung, H, Park, JY, Lee, JG, Bae, JH. The influence of androgen deprivation therapy on prostate size and voiding symptoms in prostate cancer patients in Korea. Int Neurourol J 2016;20(4):342.Google Scholar

Barry, MJ, Fowler, FJ Jr, O’Leary, MP, et al. Measurement Committee of the American Urological Association. The American Urological Association symptom index for benign prostatic hyperplasia. J Urol 1992;148(5):1549–1557.Google Scholar

British Association of Urological Surgeons (BAUS). International prostate symptoms score (IPSS) [Internet, PDF]. Available from: www.baus.org.uk/_userfiles/pages/files/Patients/Leaflets/IPSS.pdfGoogle Scholar

Dunford, C, Bell, K, Rashid, T. Genital reconstructive surgery in male to female transgender patients: a systematic review of primary surgical techniques, complication profiles, and functional outcomes from 1950 to present day. Eur Urol Focus 2021;7(2):464–471.Google Scholar

Dreher, PC, Edwards, D, Hager, S, et al. Complications of the neovagina in male‐to‐female transgender surgery: a systematic review and meta‐analysis with discussion of management. Clin Anat 2018;31(2):191–199.CrossRefGoogle ScholarPubMed

de Nie, I, de Blok, CJ, van der Sluis, TM, et al. Prostate cancer incidence under androgen deprivation: nationwide cohort study in trans women receiving hormone treatment. J Clin Endocrinol Metab 2020;105(9):e3293–e3299.Google Scholar

Antunes-Lopes, T, Vale, L, Coelho, AM, et al. The role of urinary microbiota in lower urinary tract dysfunction: a systematic review. Eur Urol Focus 2020;6(2):361–369.Google Scholar

Birse, KD, Kratzer, K, Zuend, CF, et al. The neovaginal microbiome of transgender women post-gender reassignment surgery. Microbiome 2020;8:1–3.Google Scholar

Brubaker, L, Wolfe, A. The urinary microbiota: a paradigm shift for bladder disorders? Curr Opin Obstet Gynecol 2016;28(5):407.Google Scholar

Dy, GW, Nolan, IT, Hotaling, J, Myers, JB. Patient reported outcome measures and quality of life assessment in genital gender confirming surgery. Transl Androl Urol 2019;8(3):228.Google Scholar

Bustos, SS, Bustos, VP, Mascaro, A, et al. Complications and patient-reported outcomes in transfemale vaginoplasty: an updated systematic review and meta-analysis. Plast Reconstr Surg Glob Open 2021;9(3):e3510.Google Scholar

Kanthabalan, A, Jervis, HF, Dusoye, A, et al. PROGRESS (Patient Reported Outcomes in Genital Reconstructive Surgeries): a validated patient reported outcome measure questionnaire to assess post-operative functional improvement following feminising genital reconstructive surgery. Eur Urol 2021;79:S1584–S1584.Google Scholar

Cardinali, J, Manzer, D. The role of physical therapy in the care of transgender patients. In D. Nikolavsky & S. A. Blakely (Eds.), Urological Care for the Transgender Patient. Cham: Springer, 2021, pp. 219–226.Google Scholar

Bellringer, J. Consultant Urologist and head of Gender Surgery Services Parkside Hospital 2021, personal communication, January 2021.Google Scholar

Buncamper, ME, van der Sluis, WB, van der Pas, RS, et al. Surgical outcome after penile inversion vaginoplasty: a retrospective study of 475 transgender women. Plastic Reconstr Surg 2016;138(5):999–1007.Google Scholar

Jin, B, Turner, L, Walters, WA, Handelsman, DJ. The effects of chronic high dose androgen or estrogen treatment on the human prostate. J Clin Endocrinol Metab 1996;81(12):4290–4295.Google Scholar

Abelson, B, Sun, D, Que, L, et al. Sex differences in lower urinary tract biology and physiology. Biol Sex Differ 2018;9(1):1–3.Google Scholar

Thom, DH, Brown, JS. Reproductive and hormonal risk factors for urinary incontinence in later life: a review of the clinical and epidemiologic literature. J Am Geriatr Soc 1998;46(11):1411–1417.Google Scholar

Matsuo, K, Ichihara, K, Gotoh, M, Masumori, N. Comparison of the uroflowmetry parameter results between transgender males undergoing gender-affirming hormone therapy and age-matched cisgender females: preliminary data. Transgend Health 2019;4(1):152–156.Google Scholar

Fitzpatrick, C, Swierzewski, SJ III, McGuire, EJ. Periurethral collagen for urinary incontinence after gender reassignment surgery. Urology 1993;42(4):458–460.Google Scholar

Brown, JS, Grady, D, Ouslander, JG, et al. Prevalence of urinary incontinence and associated risk factors in postmenopausal women. Obstet Gynecol 1999;94(1):66–70.Google Scholar

Melloni, C, Melloni, G, Rossi, M, et al. Lower urinary tract symptoms in male-to-female transsexuals: short terms results and proposal of a new questionnaire. Plastic Reconstr Surg Global Open 2016;4(3):e655.Google Scholar

Wu, JM, Matthews, CA, Conover, MM, Pate, V, Funk, MJ. Lifetime risk of stress incontinence or pelvic organ prolapse surgery. Obstet Gynecol 2014;123(6):1201.Google Scholar

Dietz, HP. The aetiology of prolapse. Int Urogynecol J 2008;19(10):1323.Google Scholar

Bucci, S, Mazzon, G, Liguori, G, et al. Neovaginal prolapse in male-to-female transsexuals: an 18-year-long experience. BioMed Res Int 2014;2014:240761. https://doi.org/10.1155/2014/240761Google Scholar

Parisi, S, Novelli, A, Olearo, E, Basile, A, Puppo, A. Traditional McCall culdoplasty compared to a modified McCall technique with double ligament suspension: anatomical and clinical outcomes. Int Urogynecol J 2020;31(10):2147–2153.Google Scholar

Kuhn, A, Santi, A, Birkhäuser, M. Vaginal prolapse, pelvic floor function, and related symptoms 16 years after sex reassignment surgery in transsexuals. Fertil Steril 2011;95(7):2379–2382.Google Scholar

Casali, TG, de Castro Paiva, KC, Rodrigues, MN, et al. Topical estradiol increases epidermal thickness and dermal collagen of foreskin prior to hypospadia surgery: randomized double blinded controlled trial. J Pediatr Urol 2019;15(4):346–352.Google Scholar

Pierpont, YN, Dinh, TP, Salas, RE, et al. Obesity and surgical wound healing: a current review. ISRN Obes 2014;2014:638936. https://doi.org/10.1155/2014/638936Google Scholar

Goddard, JC, Vickery, RM, Qureshi, A, et al. Feminizing genitoplasty in adult transsexuals: early and long‐term surgical results. BJU Int 2007;100(3):607–613.CrossRefGoogle ScholarPubMed

Stanojevic, DS, Djordjevic, ML, Milosevic, A, et al. Sacrospinous ligament fixation for neovaginal prolapse prevention in male-to-female surgery. Urology 2007;70(4):767–771.Google Scholar

Persu, C, Chapple, CR, Cauni, V, Gutue, S, Geavlete, P. Pelvic Organ Prolapse Quantification System (POP–Q): a new era in pelvic prolapse staging. J Med Life 2011;4(1):75.Google Scholar

Wallace, SL, Miller, LD, Mishra, K. Pelvic floor physical therapy in the treatment of pelvic floor dysfunction in women. Curr Opin Obstet Gynecol 2019;31(6):485–493.Google Scholar

Frederick, RW, Leach, GE. Abdominal sacral colpopexy for repair of neovaginal prolapse in male-to-female transsexuals. Urology 2004;64(3):580–581.Google Scholar

Haylen, BT, de Ridder, D, Freeman, RM, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn 2010;29(1):4–20.Google Scholar

Melloni, C, Melloni, G, Rossi, M, et al. Lower urinary tract symptoms in male-to-female transsexuals: short term results and proposal of a new questionnaire. Plast Reconstr Surg Glob Open 2016;4(3):e655.Google Scholar

Lawrence, A. Patient-reported complications and functional outcomes of male-to-female sex reassignment surgery. Arch Sex Behav 2006; 35(6):717–727.Google Scholar

Hoebeke, P, Selvaggi, G, Ceulemans, P, et al. Impact of sex reassignment surgery on lower urinary tract function. Eur Urol 2005;47(3):398–402.Google Scholar

Srinivasan, S, Soni, S. Effect of sex reassignment surgery on lower urinary tract function: a questionnaire-based study. Int J Med Res Prof 2017;3(4):215–218.Google Scholar

Kim, SY, Bang, W, Kim, MS, et al. Analysis of the prevalence and factors associated with nocturia in adult Korean men. Sci Rep 2017;7:41714.Google Scholar

Nassiri, N, Maas, M, Basin, M, Cacciamani, GE, Doumanian, LR. Urethral complications after gender reassignment surgery: a systematic review. Int J Impot Res 2020;33(8):793–800.Google Scholar

Van d Grift, TC, Pigot, G, Boudhan, S, et al. A longitudinal study of motivations before and psychosexual outcomes after genital gender-confirming surgery in transmen. J Sex Med 2017;14(12):1621–1628.Google Scholar

Parsons, M, Tissot, W, Cardozo, L, et al. Normative bladder diary measurements: night versus day. Neurourol Urodyn 2007;26:465–473.Google Scholar

Veerman, H, de Rooij, FPW, Al-Tamimi, M, et al. Functional outcomes and urological complications after genital gender-affirming surgery with urethral lengthening in transgender men. J Urol 2020;204(1):104–109.Google Scholar

Rachlin, K, Hansbury, G, Pardo, ST. Hysterectomy and oopherectomy experiences of female-to-male transgender individuals. Int J Transgend 2010;12(3):155–166.Google Scholar

Kuhn, A, Hiltebrand, R, Birkhäuser, M. Do transsexuals have micturition disorders? Eur J Obstet Gynecol Reprod Biol 2007;131(2):226–230.Google Scholar

Trum, H, Hoebeke, P, Gooren, L. Sex reassignment of transsexual people from a gynaecologist’s and urologist’s perspective. Acta Obstet Gynecol Scand 2015;94(6):563–567.Google Scholar

Bertolotto, M, Liguori, G, Bucci, S, et al. MR imaging in patients with male-to-female sex reassignment surgery: postoperative anatomy and complications. Br J Radiol 2017;90:20170062.Google Scholar

Santos, F, Leite, R, Custodio, A, et al. Testosterone stimulates growth and secretory activity of the female prostate in the adult gerbil. Biol Reprod 2006;75:370–379.Google Scholar

Saad, F, Yassin, A, Haider, A, Gooren, L. Effects of testosterone on the lower urinary tract go beyond the prostate: new insights, new treatment options. Arab J Urol 2011;9:147–152.Google Scholar

Biancardi, M, Santos, F, Madi-Rvazzi, L, et al. Testosterone promotes an anabolic increase in the rat female prostate (Skene’s paraurethral gland) which acquires a male ventral prostate phenotype. Anat Rec (Hoboken) 2010;293(12):2163–2175.CrossRefGoogle ScholarPubMed

Tek, M, Balli, E, Cimen, B, et al. The effect of testosterone replacement therapy on bladder functions and histology in ochiectomized mature male rats. Urology 2010;75(4):886–890.Google Scholar

Bryson, C, Honig, S. Genitourinary complications of gender-affirming surgery. Curr Urol Rep 2019;20(6):31.Google Scholar

Jun, MS, Santucci, RA. Urethral stricture after phalloplast. Transl Androl Urol 2019;8(3):266–272.Google Scholar

Dunford, C, Bell, K, Rashid, T. Genital reconstructive surgery in male to female transgender patients: a systematic review of primary surgical techniques, complication profiles, and functional outcomes from 1950 to present day. Eur Urol Focus 2021;7(2):464–471.Google Scholar

Middleton, I, Holden, F. Urological issues following gender reassignment surgery. Br J Nurs 2017 (urology supplement);26:18.Google Scholar

Stantucci, RA. Urethral complications after transgender phalloplasty: strategies to treat them and minimize their occurrence. Clin Anat 2018;31(2):187–190.Google Scholar

Foxman, B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 2002;8(suppl. 1A):5S–13S.Google Scholar

Bailey, RR. Urinary tract infection: some recent concepts. Can Med Assoc J 1972;107(4):316–330.Google ScholarPubMed

Toolenaar, TA, Freundt, I, Wagenvoort, JH, et al. Bacterial flora of the sigmoid neovagina. J Clin Microbiol 1993;31(12):3314–3316.Google Scholar

Weyers, S, De Sutter, P, Hoebeke, S, et al. Gynaecological aspects of the treatment and follow-up of transsexual men and women. Facts Views Vis Obgyn 2010; 2(1):35–54.Google Scholar

Combaz, N, Kuhn, A. Long-term urogynecological complications after sex reassignment surgery in transsexual patients: a retrospective study of 44 patients and diagnostic algorithm proposal. Am J Urol Res 2017;2:38–43.Google Scholar

De Haseth, K, Buncamper, M, Ozer, M, et al. Symptomatic neovaginal candidiasis in transgender women after penile inversion vaginoplasty: a clinical case series of five consecutive patients. Transgend Health 2018;3(1):105–108.Google Scholar

Radix, A, Harris, A, Belkind, U, Ting, J, Goldstein, Z. Chlamydia trachomatis infection of the neovagina in transgender women. Open Forum Infect Dis 2019;6(11):ofz470.Google Scholar

Bodsworth, N, Davies, S. Gonococcal infection of the neovagina in a male-to-female transsexual. Sex Transm Dis 1994;21(4):211–212.Google Scholar

Nikolavsky, D, Hughes, M, Zhao, L. Urologic complications after phalloplasty or metoidioplasty. Clin Plast Surg 2018;45(3):425–435.Google Scholar

Chaudhry, S, Craig, P, Calonje, E, Neill, S. Genital lichen sclerosus in a case of male-to-female gender reassignment. Clin Exp Dermatol 2006;31(5):656–658.Google Scholar

Nickel, JC. Interstitial cystitis: characterisation and management of an enigmatic urologic syndrome. Rev Urol 2002;4(3):112–121.Google Scholar

Kim, H-J. Update on the pathology and diagnosis of interstitial cystitis/bladder pain syndrome: a review. Int Neurourol J 2016;20(1):13–17.Google Scholar

Bailey, RR. Urinary tract infection: some recent concepts. Can Med Assoc J 1972;107(4):316–330.Google Scholar

Peters, KM, Carrico, DJ. Frequency, urgency and pelvic pain: treating the pelvic floor versus the epithelium. Curr Urol Rep 2006;7(6):450–455.Google Scholar

Butrick, CW. Pelvic floor hypertonic disorders: identification and management. Obstet Gynecol Clin North Am 2009;36(3):707–722.Google Scholar

Wallace, SL, Miller, LD, Mishra, K. Pelvic floor physical therapy in the treatment of pelvic floor dysfunction in women. Curr Opin Obstet Gynecol 2019;31(6):485–493.Google Scholar

Jiang, DD, Gllagher, S, Burchill, L, Berli, J, Dugi, D. Implementation of a pelvic floor physical therapy program for transgender women undergoing gender-affirming vaginoplasty. Obstet Gynecol 2019;133(5):1003–1011.Google Scholar

Manrique, O, Adabi, K, Huang, T, et al. Assessment of pelvic floor anatomy for male-to-female vaginoplasty and the role of physical therapy on functional and patient-reported outcomes. Ann Plast Surg 2019;82(6):661–666.Google Scholar

Nygaard, I, Barber, M, Burgio, K, et al. Prevalence of symptomatic pelvic floor disorders in US women. JAMA 2008;300(11):1311–1316.Google Scholar

James, SE, Herman, JL, Rankin, S, et al. The Report of the 2015 U.S. Transgender Survey. Washington, DC: National Center for Transgender Equality, 2016.Google Scholar

Bandini, E, Fischer, A, Ricca, V, et al. Childhood maltreatment in subjects with male-to-female gender identity disorder. Int J Impot Res 2001;23:276–285.Google Scholar

Kussin-Shoptaw, AL, Fletcher, JB, Reback, CJ. Physical and/or sexual abuse is associated with increased psychological and emotional distress among transgender women. LGBT Health 2017;4(4):268–274.Google Scholar

Cicowski, SB, Dunivan, GC, Komesu, YM, Rogers, RG. Sexual abuse history and pelvic floor disorders in women. South Med J 2013; 106(12):675–678.Google Scholar

Beck, JJH, Elzevier, HW, Pelger, RCM, Putter, H, Voorham-van der Zalm, PJ. Multiple pelvic floor complaints are correlated with sexual abuse history. J Sex Med 2009;6(1):193–198.Google Scholar

De Brouwer, IJ, Elaut, E, Becker-Hebly, I, et al. Aftercare needs following gender-affirming surgeries: findings from the ENIGI Multicenter European Follow-Up Study. J Sex Med 2021;18(11):1921–1932.Google Scholar

Institute of Medicine (US) Committee on Advancing Pain Research, Care, and Education. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. Washington, DC: National Academies Press, 2011. Available from: www.ncbi.nlm.nih.gov/books/NBK91497/Google Scholar

Emans, SJ, Laufer, MR. Emans, Laufer, Goldstein’s Pediatric and Adolescent Gynecology, 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2011.Google Scholar

Aloisi, AM, Bachiocco, V, Costantino, A, et al. Cross-sex hormone administration changes pain in transsexual women and men. Pain 2007;132(Suppl 1):S60–67. https://doi.org/10.1016/j.pain.2007.02.006Google Scholar

Valashany, BT, Janghorbani, M. Quality of life of men and women with gender identity disorder. Health Qual Life Outcomes 2018;16(1):167. https://doi.org/10.1186/s12955-018-0995-7Google Scholar

Dragon, CN, Guerino, P, Ewald, E, Laffan, AM. Transgender medicare beneficiaries and chronic conditions: exploring fee-for-service claims data. LGBT Health 2017;4(6):404–411. https://doi.org/10.1089/lgbt.2016.0208Google Scholar

Strath, LJ, Sorge, RE, Owens, MA, et al. Sex and gender are not the same: why identity is important for people living with HIV and chronic pain. J Pain Res 2020;13:829–835. https://doi.org/10.2147/JPR.S248424Google Scholar

Guillamon, A, Junque, C, Gómez-Gil, E. A review of the status of brain structure research in transsexualism. Arch Sex Behav 2016;45:1615–1648. https://doi.org/10.1007/s10508-016-0768-5Google Scholar

Hardacker, CT, Baccellieri, A, Mueller, ER, et al. Bladder health experiences, perceptions and knowledge of sexual and gender minorities. Int J Environ Res Public Health 2019;16(17):3170. https://doi.org/10.3390/ijerph16173170Google Scholar

Detloff, M. Gender please, without the gender police: rethinking pain in archetypal narratives of butch, transgender, and FTM masculinity. J Lesbian Stud 2006;10(1–2):87–105. https://doi.org/10.1300/J155v10n01_05Google Scholar

James, SE, Herman, JL, Keisling, M, Mottet, L, Anafi, M. The Report of the 2015 US Transgender Survey. Washington, DC: National Center for Transgender Equality, 2016.Google Scholar

Weyers, S, Elaut, E, De Sutter, P, et al. Long-term assessment of the physical, mental, and sexual health among transsexual women. J Sex Med 2009;6(3):752–760. https://doi.org/10.1111/j.1743-6109.2008.01082.xGoogle Scholar

Tree-McGrath, CAF, Puckett, JA, Reisner, SL, Pantalone, DW. Sexuality and gender affirmation in transgender men who have sex with cisgender men. Int J Transgend 2018;19(4):389–400. https://doi.org/10.1080/15532739.2018.1463584Google Scholar

Grimstad, FW, Boskey, E, Grey, M. New-onset abdominopelvic pain after initiation of testosterone therapy among trans-masculine persons: a community-based exploratory survey. LGBT Health 2020;7(5):248–253. https://doi.org/10.1089/lgbt.2019.0258Google Scholar

White Hughto, JM, Reisner, SL. A systematic review of the effects of hormone therapy on psychological functioning and quality of life in transgender individuals. Transgend Health 2016;1(1):21–31. https://doi.org/10.1089/trgh.2015.0008Google Scholar

Lutgendorf, MA. Intimate partner violence and women’s health. Obstet Gynecol 2019;134(3):470–480. https://doi.org/10.1097/AOG.0000000000003326Google Scholar

Raja, S, Hasnain, M, Hoersch, M, Gove-Yin, S, Rajagopalan, C. Trauma informed care in medicine: current knowledge and future research directions. Fam Community Health 2015;38(3):216–226. https://doi.org/10.1097/FCH.0000000000000071Google Scholar

Poteat, T, Malik, M, Cooney, E. Understanding the health effects of binding and tucking for gender affirmation. J Clin Transl Sci 2018;2(S1):76–76. https://doi.org/10.1017/cts.2018.268Google Scholar

Anandan, L, Mohammed, A. Surgical management of buried penis in adults. Cent European J Urol 2018;71(3):346–352. https://doi.org/10.5173/ceju.2018.1676Google Scholar

Wein, AJ, Kavoussi, LR, Partin, AW, Peters, CA. Campbell-Walsh Urology: 4-Volume Set, 11th ed. Amsterdam: Elsevier, 2015.Google Scholar

Bouskine, A, Nebout, M, Mograbi, B, et al. Estrogens promote human testicular germ cell cancer through a membrane-mediated activation of extracellular regulated kinase and protein kinase A. Endocrinology 2008;149(2):565–573. https://doi.org/10.1210/en.2007-1318Google Scholar

Wynder, JL, Nicholson, TM, DeFranco, DB, Ricke, WA. Estrogens and male lower urinary tract dysfunction. Curr Urol Rep 2015;16(9):61. https://doi.org/10.1007/s11934-015-0534-6Google Scholar

Sidhu, S, Parikh, T, Burman, KD. Endocrine changes in obesity. In Feingold, KR, Anawalt, B, Boyce, A, et al., Eds. Endotext. MDText.com Inc., 2000. Available from: www.ncbi.nlm.nih.gov/books/NBK279053/Google Scholar

Chidi-Ogbolu, N, Baar, K. Effect of estrogen on musculoskeletal performance and injury risk. Front Physiol 2019;9:1834. https://doi.org/10.3389/fphys.2018.01834Google Scholar

Gyang, A, Hartman, M, Lamvu, G. Musculoskeletal causes of chronic pelvic pain: what a gynecologist should know. Obstet Gynecol 2013;121(3):645–650. https://doi.org/10.1097/AOG.0b013e318283ffeaGoogle Scholar

Jiang, Y, Greenwood-Van Meerveld, B, Johnson, AC, Travagli, RA. Role of estrogen and stress on the brain-gut axis. Am J Physiol Gastrointest Liver Physiol 2019;317(2):G203–G209. https://doi.org/10.1152/ajpgi.00144.2019Google Scholar

Shanthanna, H. Successful treatment of genitofemoral neuralgia using ultrasound guided injection: a case report and short review of literature. Case Rep Anesthesiol (online) 2014;2014. https://doi.org/10.1155/2014/371703Google Scholar

Ferrando, CA. Vaginoplasty complications. Clin Plast Surg 2018;45(3):361–368. https://doi.org/10.1016/j.cps.2018.03.007Google Scholar

Massie, JP, Morrison, SD, Van Maasdam, J, Satterwhite, T. Predictors of patient satisfaction and postoperative complications in penile inversion vaginoplasty. Plast Reconstr Surg 2018;141(6):911e–921e. https://doi.org/10.1097/PRS.0000000000004427Google Scholar

Cornelisse, VJ, Jones, RA, Fairley, CK, Grover, SR. The medical care of the neovagina of transgender women: a review. Sex Health 2017;14(5):442–450. https://doi.org/10.1071/SH17044Google Scholar

Grimstad, F, McLaren, H, Gray, M. The gynecologic examination of the transfeminine person after penile inversion vaginoplasty. Am J Obstet Gynecol (online) 2020. https://doi.org/10.1016/j.ajog.2020.10.002Google Scholar

Weyers, S, Verstraelen, H, Gerris, J, et al. Microflora of the penile skin-lined neovagina of transsexual women. BMC Microbiol 2009;9:102. https://doi.org/10.1186/1471-2180-9-102Google Scholar

Workowski, K, Bolan, G, Centers for Disease Control and Prevention. Sexually Transmitted Diseases Treatment Guidelines. 2015:64(No. RR-3):1–137.Google Scholar

Huh, WK, Ault, KA, Chelmow, D, et al. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. Gynecol Oncol 2015;136(2):178–182. https://doi.org/10.1016/j.ygyno.2014.12.022Google Scholar

Bucci, S, Mazzon, G, Liguori, G, et al. Neovaginal prolapse in male-to-female transsexuals: an 18-year-long experience. Biomed Res Int (online) 2014;2014. https://doi.org/10.1155/2014/240761Google Scholar

Sigurjónsson, H, Möllermark, C, Rinder, J, Farnebo, F, Lundgren, TK. Long-term sensitivity and patient-reported functionality of the neoclitoris after gender reassignment surgery. J Sex Med 2017;14(2):269–273. https://doi.org/10.1016/j.jsxm.2016.12.003Google Scholar

Stowell, JT, Grimstad, FW, Kirkpatrick, DL, et al. Imaging findings in transgender patients after gender-affirming surgery. Radiographics 2019;39(5):1368–1392. https://doi.org/10.1148/rg.2019190010Google Scholar

Maycock, LB, Kennedy, HP. Breast care in the transgender individual. J Midwifery Womens Health 2014;59(1):74–81. https://doi.org/10.1111/jmwh.12066Google Scholar

Lungu, E, Thibault-Lemyre, A, Dominguez, JM, Trudel, D, Bureau, NJ. A case of recurrent leg necrotic ulcers secondary to silicone migration in a transgender patient: radiographic, ultrasound and MRI findings. BJR Case Rep 2016;2(1):20150309. https://doi.org/10.1259/bjrcr.20150309Google Scholar

Phillips, CJ. The cost and burden of chronic pain. Rev Pain 2009;3(1):2–5. https://doi.org/10.1177/204946370900300102Google Scholar

Grimstad, FW, Fowler, KG, New, EP, et al. Uterine pathology in transmasculine persons on testosterone: a retrospective multicenter case series. Am J Obstet Gynecol 2018;220(3):257.e1–257.e7.Google Scholar

Shim, JY, Laufer, MR, Grimstad, FW. Dysmenorrhea and endometriosis in transgender adolescents. J Pediatr Adolesc Gynecol 2020;33(5):524–528. https://doi.org/10.1016/j.jpag.2020.06.001Google Scholar

Carneiro, MM, Morsch, DM, Camargos, AF, Reis, FM, Spritzer, PM. Androgen receptor and 5alpha-reductase are expressed in pelvic endometriosis. BJOG 2008;115(1):113–117. https://doi.org/10.1111/j.1471-0528.2007.01521.xGoogle Scholar

Loverro, G, Resta, L, Dellino, M, et al. Uterine and ovarian changes during testosterone administration in young female-to-male transsexuals. Taiwan J Obstet Gynecol 2016;55(5):686–691.Google Scholar

Liu, L, Li, Y, Xie, N, et al. Proliferative action of the androgen receptor in human uterine myometrial cells: a key regulator for myometrium phenotype programming. J Clin Endocrinol Metab 2013;98(1):218–227. https://doi.org/10.1210/jc.2012-2451Google Scholar

Grimstad, FW, Fowler, KG, New, EP, et al. Ovarian histopathology in transmasculine persons on testosterone: a multicenter case series. J Sex Med 2020;17(9):1807–1818. https://doi.org/10.1016/j.jsxm.2020.05.029Google Scholar

American College of Obstetricians and Gynecologists Committee on Practice Bulletins: Gynecology. ACOG Practice Bulletin No. 194: Polycystic Ovary Syndrome. Obstet Gynecol 2018;131(6):e157–e171. https://doi.org/10.1097/AOG.0000000000002656Google Scholar

Taub, RL, Ellis, SA, Neal-Perry, G, et al. The effect of testosterone on ovulatory function in transmasculine individuals. Am J Obstet Gynecol 2020; 223(2):229.e1–229.e8. https://doi.org/10.1016/j.ajog.2020.01.059Google Scholar

Gibson, DA, Simitsidellis, I, Collins, F, Saunders, PTK. Androgens, oestrogens and endometrium: a fine balance between perfection and pathology. J Endocrinol 2020;246(3):R75–R93. https://doi.org/10.1530/JOE-20-0106Google Scholar

Carswell, JM, Roberts, SA. Induction and maintenance of amenorrhea in transmasculine and nonbinary adolescents. Transgend Health 2017;2(1):195–201. https://doi.org/10.1089/trgh.2017.0021Google Scholar

Hembree, WC, Cohen-Kettenis, PT, Gooren, L, et al. Endocrine treatment of gender-dysphoric/gender-incongruent persons: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2017;102(11):3869–3903. https://doi.org/10.1210/jc.2017-01658Google Scholar

Pinkerton, JV, Goldstein, SR. Endometrial safety: a key hurdle for selective estrogen receptor modulators in development. Menopause 2010;17(3):642–653. https://doi.org/10.1097/gme.0b013e3181c4f1d6Google Scholar

Winston McPherson, G, Long, T, Salipante, SJ, et al. The vaginal microbiome of transgender men. Clin Chem 2019;65(1):199–207. https://doi.org/10.1373/clinchem.2018.293654Google Scholar

Moulder, J, Carrillo, J, Carey, E. Pelvic pain in the transgender man. Curr Obstet Gynecol Rep (online) 2020;9(6). https://doi.org/10.1007/s13669-020-00293-xGoogle Scholar

Bachmann, G, Bouchard, C, Hoppe, D, et al. Efficacy and safety of low-dose regimens of conjugated estrogens cream administered vaginally. Menopause 2009;16(4):719–727. https://doi.org/10.1097/gme.0b013e3181a48c4eGoogle Scholar

Mayoglou, L, Dulabon, L, Martin-Alguacil, N, Pfaff, D, Schober, J. Success of treatment modalities for labial fusion: a retrospective evaluation of topical and surgical treatments. J Pediatr Adolesc Gynecol 2009;22(4):247–250. https://doi.org/10.1016/j.jpag.2008.09.003Google Scholar

American College of Obstetricians and Gynecologists Committee on Gynecologic Practice, American Society for Colposcopy and Cervical Pathology (ASCCP). Committee Opinion No 673: Persistent Vulvar Pain. Obstet Gynecol 2016;128(3):e78–84. https://doi.org/10.1097/AOG.0000000000001645Google Scholar

UCSF Transgender Care, Department of Family and Community Medicine, University of California San Francisco. Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People, 2nd ed. Edited by MB Deutsch. Published 2016. Available from: transcare.ucsf.edu/guidelinesGoogle Scholar

Yang, CC, Miller, JL, Omidpanah, A, Krieger, JN. Physical examination for men and women with urological chronic pelvic pain syndromes: a MAPP network study. Urology 2018;116:23–29. https://doi.org/10.1016/j.urology.2018.03.021Google Scholar

Matsuo, K, Ichihara, K, Gotoh, M, Masumori, N. Comparison of the uroflowmetry parameter results between transgender males undergoing gender-affirming hormone therapy and age-matched cisgender females: preliminary data. Transgend Health 2019;4(1):152–156. https://doi.org/10.1089/trgh.2019.0025Google Scholar

Raz, R. Urinary tract infection in postmenopausal women. Korean J Urol 2011;52(12):801–808. https://doi.org/10.4111/kju.2011.52.12.801Google Scholar

Brandsborg, B, Nikolajsen, L, Hansen, CT, Kehlet, H, Jensen, TS. Risk factors for chronic pain after hysterectomy: a nationwide questionnaire and database study. Anesthesiology 2007;106(5):1003–1012. https://doi.org/10.1097/01.anes.0000265161.39932.e8Google Scholar

Remington, AC, Morrison, SD, Massie, JP, et al. Outcomes after phalloplasty: do transgender patients and multiple urethral procedures carry a higher rate of complication? Plast Reconstr Surg 2018;141(2):220e–229e. https://doi.org/10.1097/PRS.0000000000004061Google Scholar

Pigot, GLS, Al-Tamimi, M, Ronkes, B, et al. Surgical outcomes of neoscrotal augmentation with testicular prostheses in transgender men. J Sex Med 2019;16(10):1664–1671. https://doi.org/10.1016/j.jsxm.2019.07.020Google Scholar

van der Sluis, WB, Pigot, GLS, Al-Tamimi, M, et al. A retrospective cohort study on surgical outcomes of penile prosthesis implantation surgery in transgender men after phalloplasty. Urology 2019;132:195–201. https://doi.org/10.1016/j.urology.2019.06.010Google Scholar

Shah, T, Wang, R. A review of factors affecting patient satisfaction with inflatable penile prosthesis. Sex Med Rev (online) 2020. https://doi.org/10.1016/j.sxmr.2020.04.001Google Scholar

Lee, CH, Akin-Olugbade, O, Kirschenbaum, A. Overview of prostate anatomy, histology, and pathology. Endocrinol Metab Clin North Am 2011;40(3):565–575, viii–ix.Google Scholar

Ittmann, M. Anatomy and histology of the human and murine prostate. Cold Spring Harb Perspect Med 2018;8(5):a030346.Google Scholar

McNeal, JE. Anatomy of the prostate and morphogenesis of BPH. Prog Clin Biol Res 1984;145:27–53.Google Scholar

Villers, A, Steg, A, Boccon-Gibod, L. Anatomy of the prostate: review of the different models. Eur Urol 1991;20(4):261–268.Google Scholar

Rodriguez, FD, Camacho, A, Bordes, SJ, et al. Female ejaculation: an update on anatomy, history, and controversies. Clin Anat 2021;34(1):103–107.Google Scholar

Aaron, L, Franco, OE, Hayward, SW. Review of prostate anatomy and embryology and the etiology of benign prostatic hyperplasia. Urol Clin North Am 2016;43(3):279–288.Google Scholar

Vuichoud, C, Loughlin, KR. Benign prostatic hyperplasia: epidemiology, economics and evaluation. Can J Urol 2015;22 (Suppl 1):1–6.Google Scholar

Devlin, CM, Simms, MS, Maitland, NJ. Benign prostatic hyperplasia: what do we know? BJU Int 2021;127(4):389–399.Google Scholar

Huggins, C, Hodges, CV. Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate. CA Cancer J Clin 1972;22(4):232–240.Google Scholar

Morgentaler, A, Traish, AM. Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth. Eur Urol 2009;55(2):310–320.Google Scholar

Khera, M, Crawford, D, Morales, A, Salonia, A, Morgentaler, A. A new era of testosterone and prostate cancer: from physiology to clinical implications. Eur Urol 2014;65(1):115–123.Google Scholar

Schatten, H. Brief overview of prostate cancer statistics, grading, diagnosis and treatment strategies. Adv Exp Med Biol 2018;1095:1–14.Google Scholar

Swerdloff, RS, Dudley, RE, Page, ST, Wang, C, Salameh, WA. Dihydrotestosterone: biochemistry, physiology, and clinical implications of elevated blood levels. Endocr Rev 2017;38(3):220–254.Google Scholar

Neyman, A, Fuqua, JS, Eugster, EA. Bicalutamide as an androgen blocker with secondary effect of promoting feminization in male-to-female transgender adolescents. J Adolesc Health 2019;64(4):544–546.Google Scholar

Defreyne, J, Nota, N, Pereira, C, et al. Transient elevated serum prolactin in trans women is caused by cyproterone acetate treatment. LGBT Health 2017;4(5):328–336.Google Scholar

Weill, A, Nguyen, P, Labidi, M, et al. Use of high dose cyproterone acetate and risk of intracranial meningioma in women: cohort study. Br Med J 2021;372:n37.Google Scholar

T’Sjoen, G, Arcelus, J, Gooren, L, Klink, DT, Tangpricha, V. Endocrinology of transgender medicine. Endocr Rev 2019;40(1):97–117.Google Scholar

Bonkhoff, H. Estrogen receptor signaling in prostate cancer: implications for carcinogenesis and tumor progression. Prostate 2018;78(1):2–10.Google Scholar

King, KJ, Nicholson, HD, Assinder, SJ. Effect of increasing ratio of estrogen: androgen on proliferation of normal human prostate stromal and epithelial cells, and the malignant cell line LNCaP. Prostate 2006;66(1):105–114.Google Scholar

de Nie, I, de Blok, CJM, van der Sluis, TM, et al. Prostate cancer incidence under androgen deprivation: nationwide cohort study in trans women receiving hormone treatment. J Clin Endocrinol Metab 2020;105(9):e3293–e3299.Google Scholar

Trum, HW, Hoebeke, P, Gooren, LJ. Sex reassignment of transsexual people from a gynecologist’s and urologist’s perspective. Acta Obstet Gynecol Scand 2015;94(6):563–567.Google Scholar

Gooren, L, Morgentaler, A. Prostate cancer incidence in orchidectomised male-to-female transsexual persons treated with oestrogens. Andrologia 2014;46(10):1156–1160.Google Scholar

Ingham, MD, Lee, RJ, MacDermed, D, Olumi, AF. Prostate cancer in transgender women. Urol Oncol 2018;36(12):518–525.Google Scholar

Deebel, NA, Morin, JP, Autorino, R, et al. Prostate cancer in transgender women: incidence, etiopathogenesis, and management challenges. Urology 2017;110:166–171.Google Scholar

Frank, RT. The formation of an artificial vagina without operation. Am J Obstet Gynecol 1938;35(6):1035–1055. https://doi.org/10.1016/S0002–9378(38)90400-4Google Scholar

Ingram, JM. The bicycle seat stool in the treatment of vaginal agenesis and stenosis: a preliminary report. Am J Obstet Gynecol 1981;140(8):867–873. https://doi.org/10.1016/S0002-9378(38)90400-4Google Scholar

Herlin, M, Bay Bjorn, A-M, Petersen, MB. Treatment of vaginal agenesis in Mayer-Rokitansky-Küster-Hauser syndrome in Denmark: a nationwide comparative study of anatomical outcome and complications. DMSc 2018;110(4):746–753. https://doi.org/10.1016/j.fertnstert.2018.05.015,-PlumX%20MetricsGoogle Scholar

Edmonds, DK, Rose, GL, Lipton, MG, Quek, J. Mayer-Rokitansky-Küster-Hauser syndrome: a review of 245 consecutive cases managed by a multidisciplinary approach with vaginal dilators Fertil Steril 2012;97(3): 686–690. https://doi.org/10.1016/j.fertnstert.2011.12.038.Google Scholar

Moen, MH. Vaginal agenesis treated by coital dilatation in 20 patients. Int J Gynecol Obstet 2014;125(3)282–283.Google Scholar

Amies Oelschlager, AM, Debiec, K. Vaginal dilator therapy: a guide for providers for assessing readiness and supporting patients through the process successfully. J Pediatr Adolesc Gynecol 2019;32:354–358.Google Scholar

Liu, M, Juravic, M, Mazza, G, Krychman, MK. Vaginal dilators: issues and answers. Sex Med Rev 2021;9(2):212–220.Google Scholar

Lee, Y. Patients’ perception and adherence to vaginal dilator therapy: a systemic review and synthesis employing symbolic interactionism. Patient Prefer Adherence 2018;12:551–560.Google Scholar

Nguyen, RH, Turner, RM, Rydell, SA, Maclehose, RF, Harlow, BL. Perceived stereotyping and seeking care for chronic vulvar pain. Pain Med 2013;14(10):1461–1467. https://doi.org/10.1111/pme.12151Google Scholar

Lubotzki, FP, Butow, P, Hunt, C, et al. A psychosexual rehabilitation booklet increases vaginal dilator adherence and knowledge in women undergoing pelvic radiation therapy for gynecological or anorectal cancer: a randomized controlled trial. Clin Oncol 2019;31:124–131.Google Scholar

Larish, AM, Dickson, RR, Kudgus, RA, et al. Vaginal diazepam for nonrelaxing pelvic floor dysfunction: the pharmacokinetic profile. J Sex Med 2019;16(6):763–766. https://doi.org/10.1016/j.jsxm.2019.03.003Google Scholar

Weyers, S, Verstraelen, H, Gerris, J, et al. Microflora of the penile skin-lined neovagina of transsexual women. BMC Microbiol 2009;9(1):102.Google Scholar

Miller, TJ, Wilson, SC, Maasie, JP, Morrison, SD, Satterwhite, T. Breast augmentation in male-to-female transgender patients. Technical considerations and outcomes. JPRAS Open 2019;21:63–74. https://doi.org/10.1016/j.jpra.2019.03.003Google Scholar

Van Boerum, MS, Salibian, AA, Bluebond-Langner, R, Agarwal, C. Chest and facial surgery for the transgender patient. Transl Androl Urol 2019;8:219–227. https://doi.org/10.21037/tau.2019.06.18Google Scholar

Yerke, AF, Mitchell, V. Am I man enough yet? A comparison of the body transition, self-labeling, and sexual orientation of two cohorts of female-to-male transsexuals. Int J Transgend 2011;13:64–67. https://doi.org/10.1080/15532739.2011.622125Google Scholar

Poudrier, G, Nolan, IT, Cook, TE, et al. Assessing quality of life and patient-reported satisfaction with masculinizing top surgery: a mixed-methods descriptive survey study. Plast Reconstr Surg 2019;143:272–279. https://doi.org/10.1097/PRS-0000000000005113Google Scholar

Harrison, B, Khansa, I, Janis, JE. Evidence-based strategies to reduce postoperative complications in plastic surgery. Plast Reconstr Surg 2016;137(1):351–360. https://doi.org/10.1097/PRS.0000000000002774Google Scholar

Monstrey, S, Selvaggi, G, Ceulemans, P, et al. Chest wall contouring surgery in female-to-male transsexuals: a new algorithm. Plast Reconstr Surg 2008;121(3):849–859. https://doi.org/10.1097/01.prs.0000299921.15447.b2Google Scholar

Cregten-Escobar, P, Bouman, MB, Buncamper, ME, Mullender, MG. Subcutaneous mastectomy in female-to-male transsexuals: a retrospective cohort-analysis of 202 patients. J Sex Med 2012;9(12):3148–3153. https://doi.org/10.1111/j.1743-6109.2012.02939.xGoogle Scholar

Bowman, C, Goldberg, JM. Care of the patient undergoing sex reassignment surgery. Int J Transgenderism 2006;9(3–4):135–165. https://doi.org/10.1300/J485v09n03_07Google Scholar

Hage, JJ, van Kesteren, PJ. Chest wall contouring in female-to-male transsexuals: basic considerations and review of the literature. Plast Reconstr Surg 1995;96(2):386–391. https://doi.org/10.1097/00006534-199508000-00019Google Scholar

Hage, JJ, Bloem, JJ. Chest wall contouring for female-to-male transsexuals: Amsterdam experience. Ann Plast Surg 1995;34(1):59–66. https://doi.org/10.1097/00000637-199501000-00012Google Scholar

Jarrett, BA, Corbet, AL, Gardner, IH, Weinand, JD, Peitzmeier, SM. Chest binding and care seeking among transmasculine adults: a cross-sectional study. Transgend Health 2018;3:170–178.Google Scholar

Van de Grift, TC, Elfering, L, Bouman, MB, Buncamper, ME, Mullender, MG. Surgical indications and outcomes of mastectomy in transmen: a prospective study of technical and self-reported measures. Plast Reconstr Surg 2017;140(3):415e–424e. https://doi.org/10.1097/PRS.0000000000003607Google Scholar

McEvenue, G, Xu, FZ, Cai, R, McLean, H. Female-to-male gender affirming top surgery: a single surgeon’s 15-year retrospective review and treatment algorithm. Aesthet Surg J 2017;38(1):49–57. https://doi.org/10.1093/asj/sjx116Google Scholar

Bluebond-Langner, R, Berli, JU, Sabino, J, et al. Top surgery in transgender men: how far can you push the envelope? Plast Reconstr Surg 2017;139:873e–882e. https://doi.org/10.1097/PRS.0000000000003225Google Scholar

Beer, GM, Budi, S, Seifert, B, et al. Configuration and localization of the nipple-areola complex in men. Plast Reconstr Surg 2001;108(7):1947–1952; discussion 1953. https://doi.org/10.1097/00006534-200112000-00015Google Scholar

McGregor, JC, Whallett, EJ. Some personal suggestions on surgery in large or ptotic breasts for female to male transsexuals. J Plast Reconstr Aesthet Surg 2006;59(8):893–896. https://doi.org/10.1016/j.bjps.2005.12.001Google Scholar

Ammari, T, Sluiter, EC, Gast, K, Kuzion, WM. Female-to-male gender-affirming chest reconstruction surgery. Aesth Surg J 2019;39(2):150–163. https://doi.org/10.1093/asj/sjy098Google Scholar

Wolter, A, Dietrichson, J, Scholz, T, Arens-Landwehr, A, Liebau, J. Sexual reassignment surgery in female-to-male transsexuals: an algorithm for subcutaneous mastectomy. J Plast Reconstr Aesthet Surg 2015;68(2):184–191. https://doi.org/10.1016/j.bjps.2014.10.016Google Scholar

Namba, Y, Watanabe, T, Kimata, Y. Mastectomy in female-to-male transsexuals. Acta Med Okayama 2009;63(5):243–247. https://doi.org/10.18926/AMO/31841Google Scholar

Gibson, B. Care of the child with the desire to change genders – Part II: female-to-male transition. Pediatr Nurs 2010;36(2):112–117.Google Scholar

Nelson, L, Whallett, EJ, McGregor, JC. Transgender patient satisfaction following reduction mammaplasty. J Plast Reconstr Aesthet Surg 2009;62(3):331–334. https://doi.org/10.1016/j.bjps.2007.10.049Google Scholar

Berry, MG, Curtis, R, Davies, D. Female-to-male transgender chest reconstruction: a large consecutive, single-surgeon experience. J Plast Reconstr Aesthet Surg 2012;65(6):711–719. https://doi.org/10.1016/j.bjps.2011.11.053Google Scholar

Nikolic, DV, Djordjevic, ML, Granic, M, et al. Importance of revealing a rare case of breast cancer in a female-to-male transsexual after bilateral mastectomy. World J Surg Oncol 2012;10:280. https://doi.org/10.1186/1477-7819-10-280Google Scholar

Sattari, M. Breast cancer in male-to-female transgender patients: a case for caution. Clin Breast Cancer 2015;15(1):e67–69. https://doi.org/10.1016/j.clbc.2014.08.004Google Scholar

Burcombe, RJ, Makris, A, Pittam, M, Finer, N. Breast cancer after bilateral subcutaneous mastectomy in a female-to-male trans-sexual. Breast 2003;12(4):290–293. https://doi.org/10.1016/s0960-9776(03)00033-xGoogle Scholar